`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MERCK SHARP & DOHIVIE CORP.
`
`Petitioner
`
`V.
`
`GENENTECH, INC. AND CITY OF HOPE
`
`Patent Owners
`
`U.S. Patent No. 6,331,415
`
`“Methods of Producing Irnmunoglobulins, Vectors and
`Transformed Host Cells for Use Therein”
`
`Inter Partes Review No. 2016-
`
`POWER OF ATTORNEY PURSUANT TO 37 C.F.R. § 42.10(b)
`
`
`
`Merck Sharp & Dohme Corp. hereby appoints Raymond N. Nimrod (Reg. No.
`
`31,987) of Quinn Emanuel Urquhart & Sullivan, LLP as lead counsel and Matthew
`
`A. Traupman (Reg. No. 50,832) of Quinn Emanuel Urquhart & Sullivan, LLP and
`
`Katherine A. Helm of Simpson Thacher & Bartlett LLP, who will be filing a motion
`
`seeking to be admitted pro hac vice, as backup counsel to represent Petitioner, real
`
`party—in—interest Merck Sharp & Dohme Corp., in the Inter Partes Review proceeding
`
`concerning U.S. Patent No. 6,331,415 before the Patent and Trial Appeal Board in the
`
`United States Patent and Trademark Office, and to transact all business connected
`
`therewith.
`
`The undersigned is authorized to sign this Power of Attorney on behalf of
`
`Petitioner, real party—in-interest Merck Sharp & Dohme Corp.
`
`DATED: June 29, 2016
`
`Merck Sharp & Dohm Corp.
`
`By: £ fl'\ATV‘.Q~’a.Q«
`
`Richard Grochala
`
`Reg. No. 31,518
`Executive Director
`
`IP Litigation